Business Description
Kronox Lab Sciences Ltd
ISIN : INE0ATZ01017
Total Employee Number:
57Compare
Compare
Traded in other countries / regions
KRONOX.India IPO Date
2024-06-10Description
Kronox Lab Sciences Ltd manufactures High Purity Speciality Fine Chemicals for diversified end-user industries. The company's Fine inorganic Chemicals are used mainly as reacting agents and raw materials in the manufacturing of Active Pharmaceutical Ingredients; excipients in pharmaceutical formulations; reagents for scientific research and laboratory testing; ingredients in nutraceuticals formulations; process intermediates and fermenting agents in biotech applications; ingredients in agrochemical formulations; ingredients in personal care products; refining agents in metal refineries; and ingredients in animal health products, amongst others.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 30.33 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.04 | |||||
Interest Coverage | 225.09 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 39.25 | |||||
Beneish M-Score | -1 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1.9 | |||||
3-Year EBITDA Growth Rate | 18.2 | |||||
3-Year EPS without NRI Growth Rate | 19 | |||||
3-Year FCF Growth Rate | 22.3 | |||||
3-Year Book Growth Rate | 37.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 53.59 | |||||
9-Day RSI | 57.17 | |||||
14-Day RSI | 58.17 | |||||
3-1 Month Momentum % | 9.23 | |||||
6-1 Month Momentum % | 30.18 | |||||
12-1 Month Momentum % | -7.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 7.6 | |||||
Quick Ratio | 6.8 | |||||
Cash Ratio | 4.7 | |||||
Days Inventory | 55.5 | |||||
Days Sales Outstanding | 71.16 | |||||
Days Payable | 53.19 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.27 | |||||
Dividend Payout Ratio | 0.06 | |||||
Forward Dividend Yield % | 0.27 | |||||
5-Year Yield-on-Cost % | 0.26 | |||||
Shareholder Yield % | 0.26 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 53.56 | |||||
Operating Margin % | 31.42 | |||||
Net Margin % | 27.13 | |||||
EBITDA Margin % | 38.74 | |||||
FCF Margin % | 19.55 | |||||
OCF Margin % | 22.69 | |||||
ROE % | 27.86 | |||||
ROA % | 25.28 | |||||
ROIC % | 41.06 | |||||
3-Year ROIIC % | 28.37 | |||||
ROC (Joel Greenblatt) % | 78.66 | |||||
ROCE % | 37.45 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 24.24 | |||||
PE Ratio without NRI | 24.24 | |||||
PEG Ratio | 1.19 | |||||
PS Ratio | 6.57 | |||||
PB Ratio | 6.02 | |||||
Price-to-Tangible-Book | 6.01 | |||||
Price-to-Free-Cash-Flow | 33.93 | |||||
Price-to-Operating-Cash-Flow | 29.24 | |||||
EV-to-EBIT | 16.83 | |||||
EV-to-EBITDA | 15.96 | |||||
EV-to-Revenue | 6.18 | |||||
EV-to-FCF | 31.64 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.24 | |||||
Price-to-Graham-Number | 2.6 | |||||
| Price-to-Net-Current-Asset-Value | 10.35 | |||||
| Price-to-Net-Cash | 18.71 | |||||
Earnings Yield (Greenblatt) % | 5.94 | |||||
FCF Yield % | 2.95 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kronox Lab Sciences Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,053.195 | ||
| EPS (TTM) (₹) | 7.767 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 54.13 | ||
| 14-Day RSI | 58.17 | ||
| 14-Day ATR (₹) | 12.2967 | ||
| 20-Day SMA (₹) | 170.4275 | ||
| 12-1 Month Momentum % | -7.79 | ||
| 52-Week Range (₹) | 96 - 222.9 | ||
| Shares Outstanding (Mil) | 37.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kronox Lab Sciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kronox Lab Sciences Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| INR 0.500000 Cash Dividend | 2026-09-09 | In 12 days | ||
| INR 0.500000 Cash Dividend | 2025-08-08 | 171.65 (+1.39%) |
Show
Entries
Kronox Lab Sciences Ltd Frequently Asked Questions
What is Kronox Lab Sciences Ltd(BOM:544187)'s stock price today?
The current price of BOM:544187 is ₹188.25. The 52 week high of BOM:544187 is ₹222.90 and 52 week low is ₹96.00.
When is next earnings date of Kronox Lab Sciences Ltd(BOM:544187)?
The next earnings date of Kronox Lab Sciences Ltd(BOM:544187) is .
Does Kronox Lab Sciences Ltd(BOM:544187) pay dividends? If so, how much?
The Dividend Yield %  of Kronox Lab Sciences Ltd(BOM:544187) is 0.27% (As of Today), Highest Dividend Payout Ratio of Kronox Lab Sciences Ltd(BOM:544187) was 0.07. The lowest was 0.06. And the median was 0.07. The  Forward Dividend Yield % of Kronox Lab Sciences Ltd(BOM:544187) is 0.27%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Kronox Lab Sciences Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers